AdaptHealth (AHCO) Cash from Operations Growth (1y) (2019 - 2026)
AdaptHealth (AHCO) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | 122.43% |
| 10 | AdaptHealth | 1.50 Bn | 1.46 Bn | 111.50 Mn | -1.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.89% |
| Dec 31, 2025 | 21.79% |
| Sep 30, 2025 | 11.54% |
| Jun 30, 2025 | -18.18% |
| Mar 31, 2025 | 94.81% |
| Dec 31, 2024 | -3.12% |
| Sep 30, 2024 | 46.11% |
| Jun 30, 2024 | 129.36% |
| Mar 31, 2024 | -65.04% |
| Dec 31, 2023 | 60.20% |
| Sep 30, 2023 | -7.65% |
| Jun 30, 2023 | -16.58% |
| Mar 31, 2023 | 111.05% |
| Dec 31, 2022 | -3.97% |
| Sep 30, 2022 | 294.54% |
| Jun 30, 2022 | -19.94% |
| Mar 31, 2022 | 261.54% |
| Dec 31, 2021 | 100.47% |
| Sep 30, 2021 | -20.87% |
| Jun 30, 2021 | 49.19% |